The efficacy and safety of influenza vaccine in pemphigus in the COVID-19 era: A randomized trial
Archives of Dermatological Research · 10.03.2026 · 318 (1)
DOI: 10.1007/s00403-026-04548-0 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Archives of Dermatological Research, online erschienen am 10.03.2026. Verfasst von Maryam Hadi und 7 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Hadi, M., Vafaeian, A., Daneshpazhooh, M., Tavakolpour, S., Soori, T., Farid, A. S., Farimani, Z., & Mahmoudi, H. (2026). The efficacy and safety of influenza vaccine in pemphigus in the COVID-19 era: A randomized trial. Archives of Dermatological Research, 318(1). https://doi.org/10.1007/s00403-026-04548-0
Vancouver
Hadi M, Vafaeian A, Daneshpazhooh M, Tavakolpour S, Soori T, Farid AS, et al. The efficacy and safety of influenza vaccine in pemphigus in the COVID-19 era: A randomized trial. Archives of Dermatological Research. 2026;318(1). doi:10.1007/s00403-026-04548-0
BibTeX
@article{Hadi2026,
author = {Hadi, Maryam and Vafaeian, Ahmad and Daneshpazhooh, Maryam and Tavakolpour, Soheil and Soori, Tahereh and Farid, Ali Salehi and Farimani, Zeinab and Mahmoudi, Hamidreza},
title = {The efficacy and safety of influenza vaccine in pemphigus in the COVID-19 era: A randomized trial},
journal = {Archives of Dermatological Research},
year = {2026},
volume = {318},
number = {1},
doi = {10.1007/s00403-026-04548-0}
}
EUVIMED